PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$25.09
+1.29%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$56.25
Range $50.00 – $60.00
Implied Upside
+124.2%
Consensus $56.25 vs current $25.09
AMEX·Healthcare·Biotechnology
$25.09
+1.29%
Mkt Cap $15.45M
No recent rating data.
Price Target (6 analysts)
$56.25
Range $50.00 – $60.00
+124.2%
Consensus $56.25 vs current $25.09